mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.47 |
0.02 |
mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.26 |
0.02 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.15 |
0.02 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |